Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

9 Results

Guidelines and Advice

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Status: Archived
ID: CED 9

Aug 2008

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Guidelines and Advice

Management of Stage I Nonseminomatous Testicular Cancer

Status: Archived
ID: 3-19

Feb 2008

Guidelines and Advice

Treatment of Acute Myeloid Leukemia in Older Patients

Status: Archived
ID: 6-14

Dec 2008

Guidelines and Advice

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025

Guidelines and Advice

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Status: Current
Version: 2

Updated

Sep 2025

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Guidelines and Advice

Systemic Treatment Emergency Preparedness Guidance Document

Status: Current

Updated

Aug 2025

Guidelines and Advice

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Status: Current
ID: 7-13
Version: 2

Updated

Sep 2025